NCT07096973Recruiting
Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery
Source: ClinicalTrials.gov · Last updated 29 Sept 2026
Brief summary (registry, in English)
The RECOVER study, titled Cardiac Rehabilitation Cohort at the Medicine Campus Davos for Exploration of Recovery, is a prospective, non-interventional, monocentric cohort study conducted at the Hochgebirgsklinik Davos. The study is sponsored by Medicine Campus Davos AG and the Kühne Foundation, with an estimated start date in July 2025 and planned completion by December 2034, with the possibility of extension. The principal investigator of the study is PD Dr. David Niederseer from Hochgebirgsklinik Davos, who also represents the study. The research team includes co-investigators such as Prof. Dr. Stefan Blankenberg and Prof. Dr. Andreas Ziegler from Cardio-CARE, Medicine Campus Davos, as well as Dr. Jan Vontobel from Hochgebirgsklinik Davos. The study will enroll patients referred to Hochgebirgsklinik Davos for cardiac rehabilitation who provide informed consent. Cardiac rehabilitation is an evidence-based therapy for patients with heart disease, including those who have undergone cardiac procedures or surgeries. The primary objectives are to evaluate baseline patient characteristics, rehabilitation strategies, predictors of recovery, and clinical outcomes during and after rehabilitation. To support this, a detailed database and biobank will be established to allow for comprehensive phenotyping, extensive clinical assessments, and long-term follow-up. RECOVER seeks to gain translational insights into how patient-specific factors - such as genetics, plasma, digital and clinical biomarkers, and comorbidities - influence long-term clinical outcomes. The goal is to identify modifiable risk factors to optimize individualized therapeutic approaches in cardiac rehabilitation.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 21 Jul 2025
- Start date
- 5 Aug 2025
- Primary completion date
- 5 Aug 2035
- Lead sponsor
- Hochgebirgsklinik Davos
- Diseases
- Heart failure, Coronary artery disease
- NCT number
- NCT07096973
What you commit to
- Study type: Observational
- Planned participants: 10000
- From 5 Aug 2025 to the primary completion date, 5 Aug 2035
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Insufficient knowledge of the German language to understand study documents, the interview, or questionnaires interview without translation
- Physical or psychological incapability to participate in the study
Who the study is looking for
- Patients undergoing CR at the HGK
- Written informed consent
- Age ≥ 18 years
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hochgebirgsklinik Davos Coordinator of this site? Confirm its status | Davos | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.